DHA: System, Test, Human Chorionic Gonadotropin: FDA Product Code 510(k) Clearances, Predicate Lineage, and Recall History (1986 to 2024)

U.S. FDA CDRH three-letter product classification DHA in Clinical Chemistry (21 CFR 862.1155) reconciled across 1986 to 2024.

Review 72 FDA 510(k) clearances, 7 recalled K-numbers, and 14 cumulative 1976 to 2026 CDRH recall notices for DHA: System, Test, Human Chorionic Gonadotropin on Predicate Ledger.

Reconciled U.S. FDA 510(k) and Recall Summary for DHA: System, Test, Human Chorionic Gonadotropin
Regulatory MetricVerified Value
Entity ClassificationFDA 3-Letter Product Code (DHA, Class 2)
Clinical Advisory SpecialtyClinical Chemistry (Panel CH)
Cleared FDA 510(k) Submissions (1976 to 2026)72 clearances (15 California, 20.8%)
Cleared 510(k)s Linked to a Recall Notice7 K-numbers (9.72% of cleared cohort)
Cumulative Historical Recall Notices (1976 to 2026)14 notices (0 Class I, 13 Class II, 1 Class III)
Currently Open vs Historical Recall StatusCumulative 1976 to 2026 FDA archive total (14 notices); verify live open vs terminated status per notice in dossier
Implantable and Life-Sustaining Clearances0 implantable (0.0%) and 0 life-sustaining
Median FDA 510(k) Review Duration76 days (90th percentile: 253 days)

Cumulative recall counts span 1976 to 2026 across U.S. FDA CDRH and openFDA public archives and combine closed historical notices with any currently open field actions. Browse all device cohorts, 20 clinical specialties, Shared 510(k) Predicate Lineage Stage, or reconciliation methodology.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.